Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Net Margin (2017 - 2026)

Nutex Health (NUTX) has disclosed Net Margin for 15 consecutive years, with 28.99% as the latest value for Q1 2026.

  • For Q1 2026, Net Margin rose 2193.0% year-over-year to 28.99%; the TTM value through Mar 2026 reached 21.86%, up 410.0%, while the annual FY2025 figure was 20.61%, 973.0% up from the prior year.
  • Net Margin hit 28.99% in Q1 2026 for Nutex Health, up from 10.95% in the prior quarter.
  • Across five years, Net Margin topped out at 38.84% in Q4 2024 and bottomed at 1488.0% in Q3 2022.
  • Average Net Margin over 5 years is 84.56%, with a median of 3.96% recorded in 2024.
  • Year-over-year, Net Margin crashed -153360bps in 2022 and then skyrocketed 148079bps in 2023.
  • Nutex Health's Net Margin stood at 18.48% in 2022, then tumbled by -315bps to 39.78% in 2023, then soared by 198bps to 38.84% in 2024, then plummeted by -72bps to 10.95% in 2025, then soared by 165bps to 28.99% in 2026.
  • According to Business Quant data, Net Margin over the past three periods came in at 28.99%, 10.95%, and 36.15% for Q1 2026, Q4 2025, and Q3 2025 respectively.